首页> 美国卫生研究院文献>other >Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice
【2h】

Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice

机译:尼古丁与被描述为阳性变构烟碱型乙酰胆碱受体调节剂的药物在体外的作用:对小鼠的歧视性刺激和低温作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Some drugs that are positive allosteric nAChR modulators in vitro, desformylflustrabromine (dFBr), PNU-120596 and LY 2087101, have not been fully characterized in vivo. These drugs were examined for their capacity to share or modify the hypothermic and discriminative stimulus effects of nicotine (1 mg/kg s.c.) in male C57Bl/6J mice. Nicotine, dFBr, and PNU-120596 produced significant hypothermia, whereas LY 2087101 (up to 100 mg/kg) did not. Nicotine dose-dependently increased nicotine-appropriate responding and decreased response rate; the respective ED50 values were 0.56 mg/kg and 0.91 mg/kg. The modulators produced no more than 38% nicotine-appropriate responding up to doses that disrupted operant responding. Rank order potency was the same for hypothermia and rate-decreasing effects: nicotine>dFBr>PNU-120596=LY 2087101. Mecamylamine and the α4β2 nAChR antagonist dihydro-β-erythroidine, but not the α7 antagonist methyllycaconitine, antagonized the hypothermic effects of nicotine. In contrast, mecamylamine did not antagonize the hypothermic effects of the modulators. The combined discriminative stimulus effects of DFBr and nicotine were synergistic, whereas the combined hypothermic effects of nicotine with either dFBr or PNU-120596 were infra-additive. PNU-120596 did not modify the nicotine discriminative stimulus, and LY 2087101 did not significantly modify either effect of nicotine. Positive modulation of nicotine at nAChRs by PNU-120596 and LY 2087101 in vitro does not appear to confer enhancement of the nAChR-mediated hypothermic or discriminative stimulus effects of nicotine. However, dFBr appears to be a positive allosteric modulator of some behavioral effects of nicotine at doses of dFBr smaller than the doses producing unwanted effects (e.g. hypothermia) through non-nAChR mechanisms.
机译:在体外,一些药物是体外变构nAChR阳性调节剂,去甲酰基氟乙溴(dFBr),PNU-120596和LY 2087101,尚未在体内得到充分表征。检查了这些药物在雄性C57Bl / 6J小鼠中分享或改变烟碱(1 mg / kg s.c.)的低温和歧视性刺激作用的能力。尼古丁,dFBr和PNU-120596产生明显的体温过低,而LY 2087101(最高100 mg / kg)则没有。尼古丁剂量依赖性地增加适当的尼古丁反应和降低的反应率; ED50分别为0.56 mg / kg和0.91 mg / kg。调节剂产生不超过38%的尼古丁适合反应,直至破坏手术反应的剂量。降低体温和降速作用的等级效力相同:尼古丁> dFBr> PNU-120596 = LY2087101。美卡明胺和α4β2nAChR拮抗剂二氢-β-赤藓碱,而不是α7拮抗剂甲基甘可尼汀,拮抗了尼古丁的降温作用。相反,美卡明胺没有拮抗调节剂的低温作用。 DFBr和尼古丁的组合判别刺激作用是协同的,而尼古丁与dFBr或PNU-120596的联合低温作用是下加性的。 PNU-120596没有改变尼古丁的判别刺激,而LY 2087101没有显着改变尼古丁的任何作用。在体外,PNU-120596和LY 2087101在nAChRs上对尼古丁的正调节作用似乎并未赋予nAChR介导的尼古丁低温或判别性刺激作用增强。但是,dFBr似乎是尼古丁某些行为效应的正变构调节剂,其剂量小于通过非nAChR机制产生不良作用(例如体温过低)的剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号